Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
May. 19 | Genocea Biosciences, Inc. Went Out of Business | CI |
May. 11 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
Financials (USD)
Sales 2020 | 1.36M | Sales 2021 | 1.64M | Capitalization | 66.64M |
---|---|---|---|---|---|
Net income 2020 | -43M | Net income 2021 | -33M | EV / Sales 2020 | 50.8 x |
Net cash position 2020 | 55.9M | Net cash position 2021 | 19.96M | EV / Sales 2021 | 28.4 x |
P/E ratio 2020 |
-2.18
x | P/E ratio 2021 |
-2.4
x | Employees | 74 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.84% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 52 | 07-02-28 | |
Girish Aakalu
PRN | Corporate Officer/Principal | - | 18-12-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 14-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | - | -100.00% | 25 |
Delayed Quote OTC Markets, March 19, 2024 at 11:27 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 58 | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-5.11% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |